Author(s):
Vitthal B. Kundgir, Tushar R. Chandan, Chandrashekhar D. Patil, Rushikesh L. Bachhav, Mayur S. Bhamare, Sunil K. Mahajan
Email(s):
vitthalkundgir357@gmail.com
DOI:
10.52711/2321-5836.2025.00045 
Address:
Vitthal B. Kundgir1*, Tushar R. Chandan1, Chandrashekhar D. Patil1, Rushikesh L. Bachhav2, Mayur S. Bhamare2, Sunil K. Mahajan3
1Department of Pharmacology, SSS’s Divine College Pharmacy, Nampur Road, Satana, Nashik, Maharashtra, India - 423301.
2Department of Quality Assurance, SSS’s Divine College Pharmacy, Nampur Road, Satana, Nashik, Maharashtra, India - 423301.
3Department of Chemistry, SSS’s Divine College Pharmacy, Nampur Road, Satana, Nashik, Maharashtra, India - 423301
.
*Corresponding Author
Published In:
Volume - 17,
Issue - 4,
Year - 2025
ABSTRACT:
Chronopharmacology is an emerging field that investigates how the timing of drug administration in relation to biological rhythms particularly circadian rhythms affects pharmacological outcomes. Circadian clocks regulate a wide array of physiological processes, including hormone secretion, metabolism, enzyme activity, and receptor expression, all of which can influence a drug’s absorption, distribution, metabolism, and excretion (ADME). This review explores the molecular basis of circadian rhythms, the mechanisms by which they modulate pharmacokinetics and pharmacodynamics, and their clinical significance across major therapeutic areas such as cardiovascular disease, cancer, asthma, metabolic and psychiatric disorders. Accumulating evidence supports the idea that synchronizing drug administration with the body's internal clock can enhance therapeutic efficacy, reduce toxicity, and improve patient outcomes- a concept known as chronotherapy. However, challenges remain in individual variability, clinical implementation, and the integration of circadian biomarkers in treatment protocols. As personalized medicine advances, chronopharmacology is poised to play a central role in optimizing drug therapy through biologically timed interventions.
Cite this article:
Vitthal B. Kundgir, Tushar R. Chandan, Chandrashekhar D. Patil, Rushikesh L. Bachhav, Mayur S. Bhamare, Sunil K. Mahajan. Drug effects by Biological Timing: A Chronopharmacological Perspective. Research Journal of Pharmacology and Pharmacodynamics. 2025;17(4):286-4. doi: 10.52711/2321-5836.2025.00045
Cite(Electronic):
Vitthal B. Kundgir, Tushar R. Chandan, Chandrashekhar D. Patil, Rushikesh L. Bachhav, Mayur S. Bhamare, Sunil K. Mahajan. Drug effects by Biological Timing: A Chronopharmacological Perspective. Research Journal of Pharmacology and Pharmacodynamics. 2025;17(4):286-4. doi: 10.52711/2321-5836.2025.00045 Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-4-7
9. REFERENCES:
1. Tamilanban. T, Mohamedmajeed. A, Chitra. V. Overview of Chronopharmacology. Research J. Pharm. and Tech. 2020; 13(9): 4457-4463.
2. Gaurav Tiwari, Awani K Rai, Vachaspati Dubey, Anil Sharma, Pranay Wal, Ankita Wal. Chronopharmaceutics: A Clinically Relevant Approach to Drug Delivery. Research J. Pharma. Dosage Forms and Tech. 2010; 2(2): 139-145.
3. Shah AM, Shah SV. Chronopharmacology: Optimizing drug therapy through biological rhythms. National Journal of Physiology, Pharmacy & Pharmacology. 2024 Sep 1; 14(9).
4. Dobrek L. Chronopharmacology in therapeutic drug monitoring—dependencies between the rhythmics of pharmacokinetic processes and drug concentration in blood. Pharmaceutics. 2021 Nov 12; 13(11): 1915.
5. Patke A, Young MW, Axelrod S. Molecular mechanisms and physiological importance of circadian rhythms. Nature Reviews Molecular cell Biology. 2020 Feb; 21(2):67-84.
6. Duong HA, Robles MS, Knutti D, Weitz CJ. A molecular mechanism for circadian clock negative feedback. Science. 2011 Jun 17; 332(6036): 1436-9.
7. Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Molecular Cancer. 2016 Dec; 15:1-4.
8. Okyar A, Ozturk Civelek D, Akyel YK, Surme S, Pala Kara Z, Kavakli İH. The role of the circadian timing system on drug metabolism and detoxification: an update. Expert Opinion on Drug Metabolism & Toxicology. 2024 Jun 2; 20(6): 503-17.
9. Dudley JA, Haworth JM, McGraw ME, Frank JD, Tizard E. Clinical relevance and implications of antenatal hydronephrosis. Archives of Disease in Childhood-Fetal and Neonatal Edition. 1997 Jan 1; 76(1): F31-4.
10. Subhashis Debnath, T. H. Harish Kumar. An Overview on Pharmacokinetics and Pharmacokinetic Modeling. Asian J. Res. Pharm. Sci. 2020; 10(2): 124-130.
11. Bicker J, Alves G, Falcão A, Fortuna A. Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics. British Journal of Pharmacology. 2020 May; 177(10): 2215-39.
12. Lombardi F. Clinical implications of present physiological understanding of HRV components. Cardiac Electrophysiology Review. 2002 Sep; 6: 245-9.
13. Diptimayee Jena, Pratishya Bhatta, Kirtimaya Mishra. Efficacy, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Rituximab (Test Product, Zydus) vs Rituximab (Reference Product, Roche/Genentech) in Patients with Diffuse Large B Cell Lymphoma (DLBCL). Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(3):203-0.
14. Reeves JD, Gallo SA, Ahmad N, Miamidian JL, Harvey PE, Sharron M, Pöhlmann S, Sfakianos JN, Derdeyn CA, Blumenthal R, Hunter E. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics. Proceedings of the National Academy of Sciences. 2002 Dec 10; 99(25): 16249-54.
15. Mavers M, Ruderman EM, Perlman H. Intracellular signal pathways: potential for therapies. Current rheumatology reports. 2009 Oct; 11(5): 378-85.
16. Pucci B, Kasten M, Giordano A. Cell cycle and apoptosis. Neoplasia. 2000 Jul 1; 2(4):291-9.
17. Witte K, Lemmer B. Rhythms and pharmacodynamics. London: Pharmaceutical Press; 2003.
18. LEMMER B. The clinical relevance of chronopharmacology in therapeutics. Pharmacological Research. 1996 Feb 1; 33(2): 107-15.
19. Gharge Deepali, Bavaskar Sunil, Todkar Pavan, Dhabale Pandurang. Pharmacogenomics: An Overview. Research J. Pharmacology and Pharmacodynamics. 2009; 1(2): 59-65.
20. Weinberg RA. How cancer arises. Scientific American. 1996 Sep 1; 275(3): 62-70.
21. Aziz SS, Iqbal R. Asthma as a Respiratory Disorder. Scientific Inquiry and Review. 2018 Apr 30; 2(2): 48-66.
22. Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. The Lancet Psychiatry. 2019 Feb 1; 6(2): 164-73.
23. Vieira S, Pinaya WH, Mechelli A. Using deep learning to investigate the neuroimaging correlates of psychiatric and neurological disorders: Methods and applications. Neuroscience & Biobehavioral Reviews. 2017 Mar 1; 74: 58-75.
24. Nagada n. Chronopharmacology for innovative drug delivery scheduling: a new paradigm. Frontline Medical Sciences and Pharmaceutical Journal. 2023 Sep 6; 3(9): 8-14.
25. Weger M, Weger BD, Gachon F. Understanding circadian dynamics: current progress and future directions for chronobiology in drug discovery. Expert Opinion on Drug Discovery. 2023 Aug 3; 18(8): 893-901.
26. Bicker J, Alves G, Falcão A, Fortuna A. Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics. British Journal of Pharmacology. 2020 May; 177(10): 2215-39.
27. Kim DW, Zavala E, Kim JK. Wearable technology and systems modeling for personalized chronotherapy. Current Opinion in Systems Biology. 2020 Jun 1; 21: 9-15.
28. Aakash Bairagi, Akhlesh K. Singhai, Ashish Jain. Artificial Intelligence: Future Aspects in the Pharmaceutical Industry an Overview. Asian Journal of Pharmacy and Technology. 2024; 14(3): 237-6.